X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

ACET

Closed

Adicet Bio Inc

0.6111
+0.0011 (+0.18%)
Last Update: 01 Jul 2025 23:25:00
Yesterday: 0.61
Day's Range: 0.61 - 0.64
Send
When Written:
 
5.835
Adicet Bio Inc is a clinical-stage biotechnology company that focuses on the development of immunotherapies for cancer and other diseases. The company's proprietary technology platform enables the engineering of allogeneic gamma delta T cells with CAR or TCR constructs for the treatment of solid and liquid tumors. Adicet Bio's lead product candidate, ADI-001, is currently in Phase 1 clinical trials for the treatment of non-Hodgkin lymphoma and solid tumors. The company is headquartered in Menlo Park, California, and was founded in 2015.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.209
X